WuXi XDC Cayman Inc. (SEHK: 2268)
Health Care · Life Sciences Tools & Services · CN
HK$82.10
+1.86% today · +19.0% 1Y
WuXi XDC Cayman Inc. (SEHK: 2268) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $13.25B and employs 2,662 people.
Over the last twelve months the share price has gained 19.0%, trading between 43.50 and 84.50.
Tweenvest scores WuXi XDC Cayman Inc. across four factors: quality 75/100, value 28/100, growth 100/100. Its strongest factor is growth.
2268 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.25B
- Revenue (TTM)
- $1.02B
- P/E
- 61.80
- EPS
- 1.15
- Dividend yield
- —
- Beta (5Y)
- -0.87
- 52-week high
- HK$84.50
- 52-week low
- HK$43.50
- Avg volume (3M)
- —
- Shares outstanding
- 1.27B
- Employees
- 2,662
- Next earnings
- —
About WuXi XDC Cayman Inc.
WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
- ISIN
- KYG9808A1058
- Founded
- 2013
- Listed since
- Nov 17, 2023
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Revvity, Inc.NYSE: RVTY | $17.20B | $154.55 | +0.24% |
| Medpace Holdings, Inc.NasdaqGS: MEDP | $17.08B | $619.31 | +1.19% |
| Eurofins Scientific SEENXTPA: ERF | $14.99B | €77.66 | +0.70% |
| Charles River Laboratories International, Inc.NYSE: CRL | $14.41B | $301.40 | -0.13% |
| Tempus AI, Inc.NasdaqGS: TEM | $12.80B | $67.95 | -4.20% |
| ICON Public Limited CompanyNasdaqGS: ICLR | $12.67B | $165.81 | +1.00% |
| Genscript Biotech CorporationSEHK: 1548 | $12.32B | HK$42.40 | -3.02% |
| Bio-Techne CorporationNasdaqGS: TECH | $11.36B | $72.47 | +0.01% |
Figures last refreshed Oct 11, 2026.